Professor Craig Jamieson
University of Strathclyde
Academic Principal Investigator
Our Research
An industry-academia partnership, leveraging a pioneering research-driven alliance, that will drive and deliver the collaborative development of innovative strategies for the construction and evaluation of emerging therapeutic modalities which reside outside traditional drug space.
Oligonucleotide Synthesis
Optimising cellular delivery and evaluation of oligonucleotides
Heterobifunctionals
Expanding the aperture of targeted degradation
Data-Driven Design
Accelerating the design and synthesis of emerging modalities using AI/ML and computational chemistry
Our Team Leads
Dr Tim Barrett
Modality Platform Technologies
GSK Lead
Dr Laura Paterson
University of Strathclyde
Project Manager
